Intron 6 SNP rs35599367[T] in CYP3A4 results in decreased expression and activity of CYP3A4 and carriers of the T allele require significantly lower doses of statins to treat dyslipidemia (Elens et al., 2011; Wang et al., 2011). The gene discussed is CYP3A4; the disease is metabolic syndrome.